
Please try another search
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-387, an investigational, that is in Phase 2/3 clinical trial for human immunoglobulin G2 monoclonal antibody that binds human interleukin-1 receptor 1, inhibiting IL-1a, IL-1ß-mediated signaling for the treatment of advance recurrent pericarditis by providing the added convenience of monthly subcutaneous dosing with a liquid formulation. Its preclinical products include KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody. The company was formerly known as Kiniksa Pharmaceuticals, Ltd and changed its name tpKiniksa Pharmaceuticals International, plc in June 2024. The company was incorporated in 2015 and is based in London, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Robert J. Desnick | - | - | Chairman of Scientific Advisory Board |
Sanj K. Patel | 55 | 2015 | CEO & Chairman of the Board |
Richard S. Levy | 66 | 2019 | Independent Director |
Barry D. Quart | 67 | 2015 | Independent Director |
Tracey L. McCain | 56 | 2018 | Independent Director |
G. Bradley Cole | 68 | 2020 | Independent Director |
M. Cantey Boyd | 46 | 2024 | Independent Director |
Stephen R. Biggar | 55 | 2015 | Independent Director |
Thomas R. Malley | 57 | 2016 | Independent Director |
Felix James Baker | 56 | 2015 | Lead Independent Director |
Kimberly J. Popovits | 67 | 2018 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review